news
FDA awards 11 grants for rare disease treatment developments
The FDA has awarded 11 grants equating to about $25 million of funding to clinical trials for the development of rare disease treatments.
List view / Grid view
Boston Children's Hospital
news
New Drug Application submitted for first-ever Progeria treatment
A New Drug Application has been submitted to the FDA for lonafarnib, the first-ever treatment for Progeria and Progeroid Laminopathies.
news
Most FDA required post-marketing drug studies are missing
The FDA requires drugs to be tested on children after they have been approved for adults, however two thirds of these are not happening...
